We are live on ! Find out more
ARTC

ARTHROCARE CORP
ARTC

Delisted

ARTC was delisted on the 29th of May, 2014.

118 hedge funds and large institutions have $917M invested in ARTHROCARE CORP in 2013 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 46 increasing their positions, 40 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 13

15% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 40

2% more funds holding

Funds holding: 116118 (+2)

4% more capital invested

Capital invested by funds: $878M → $917M (+$38.9M)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

13% less call options, than puts

Call options by funds: $292K | Put options by funds: $334K

Holders
118
Holders Change
+2
Holders Change %
+1.72%
% of All Funds
3.82%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
16
Increased
46
Reduced
40
Closed
13
Calls
$292K
Puts
$334K
Net Calls
-$42K
Net Calls Change
-$139K
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$7.83M -$6.98M -200,000 -48%
Morgan Stanley
27
Morgan Stanley
New York
$7.53M +$1.89M +54,209 +34%
TAM
28
Tiverton Asset Management
Delaware
$7.12M
TA
29
Teachers Advisors
New York
$6.79M +$392K +11,221 +6%
TCIM
30
TIAA CREF Investment Management
New York
$6.62M +$439K +12,574 +7%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$6.39M +$1.4M +40,103 +29%
RFC
32
Russell Frank Company
Washington
$6.27M -$221K -6,320 -3%
HW
33
Hancock Whitney
Mississippi
$5.69M +$1.22M +35,000 +28%
WC
34
Wexford Capital
Florida
$5.49M -$408K -11,680 -7%
NTC
35
North Tide Capital
Massachusetts
$5.46M +$5.36M +153,600 New
TC
36
TFS Capital
Pennsylvania
$5.34M +$454K +12,994 +9%
BCM
37
Breithorn Capital Management
New York
$5.19M +$5.09M +145,860 New
Charles Schwab
38
Charles Schwab
California
$4.67M +$223K +6,395 +5%
Geode Capital Management
39
Geode Capital Management
Massachusetts
$4.54M +$301K +8,622 +7%
D.E. Shaw & Co
40
D.E. Shaw & Co
New York
$4.48M +$823K +23,570 +23%
JP Morgan Chase
41
JP Morgan Chase
New York
$4.45M +$1.27M +36,256 +41%
Tudor Investment Corp
42
Tudor Investment Corp
Connecticut
$4.45M -$126K -3,600 -3%
SCA
43
SAC Capital Advisors
Connecticut
$4.18M -$22M -631,360 -84%
AQR Capital Management
44
AQR Capital Management
Connecticut
$4.16M +$897K +25,700 +28%
BIM
45
BlackRock Investment Management
Delaware
$4.16M +$61.4K +1,759 +2%
OAM
46
Oxford Asset Management
United Kingdom
$4.12M +$1.48M +42,384 +58%
Axa
47
Axa
France
$3.82M +$13.8K +395 +0.4%
CII
48
CR Intrinsic Investors
Connecticut
$3.61M -$1.08M -30,800 -23%
GAM
49
Gotham Asset Management
New York
$3.52M +$2.77M +79,357 +408%
BNP Paribas Asset Management
50
BNP Paribas Asset Management
France
$3.5M -$307K -8,803 -8%

ARTC Hedge Fund Activity: Q3 2013 in Review

118 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in ARTHROCARE CORP (ARTC) for Q3 2013, worth a combined $917M — up 4.4% from $878M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ARTC positions and 13 closed out — a net gain of 3 holders — while 46 added to existing stakes and 40 trimmed.

The largest buyer was Redmile Group, opening a new position worth an estimated $12M. The largest seller was SAC Capital Advisors, cutting an estimated $22M.

  • 118 institutional investors held ARTHROCARE CORP (ARTC) as of Q3 2013, up from 116 in Q2 2013.
  • Funds reported $917M of ARTHROCARE CORP stock for Q3 2013, up 4.4% quarter-over-quarter.
  • 16 funds opened new ARTHROCARE CORP positions in Q3 2013 and 13 closed out, a net change of +3 holders.
  • The largest ARTHROCARE CORP buyer in Q3 2013 was Redmile Group, an estimated $12M added.
  • The largest ARTHROCARE CORP seller in Q3 2013 was SAC Capital Advisors, an estimated $22M sold.

Based on aggregated 13F filings for Q3 2013.